transformative medicines

Actionable Insights Powered by AI

Roche Acquires Regor’s CDK Inhibitors for $850M to Enhance Breast Cancer Portfolio

Roche, Regor Therapeutics, CDK inhibitors, breast cancer, Genentech, pharmaceutical acquisition, transformative medicines